Ted Kennedy and Glioblastoma: A Look at an Aggressive Brain Tumor

What Kennedy's doctors announced

On May 17, 2008, Senator Edward "Ted" Kennedy had a seizure at his home on Cape Cod. He was flown to Massachusetts General Hospital in Boston. Doctors looked first for a stroke and ruled that out. Three days later his medical team made the finding public. Neurologist Lee Schwamm and physician Larry Ronan said imaging had found a malignant glioma in the left parietal lobe. That is the upper rear part of the brain. Kennedy was 76.

He had surgery on June 2, 2008, at Duke University Medical Center. His neurosurgeon, Dr. Allan Friedman, said afterward that the operation "was successful and accomplished our goals." Kennedy went back to parts of his public life. He died on August 25, 2009, at age 77.

That is the public record, and this article stays inside it. His doctors named a malignant glioma. They did not release a tumor grade. The rest of this page is about the disease, drawn from federal sources.

Glioma, glioblastoma, and the words in between

The brain runs on two kinds of cells. Neurons carry signals. Glial cells hold the tissue together, feed the neurons, and clean up waste. A glioma is a tumor that grows out of glial cells.

Pathologists grade brain tumors from I to IV. The National Cancer Institute explains it simply. Grade I cells look close to normal and grow slowly. Grade IV cells look nothing like normal cells and grow and spread very fast.

Glioblastoma is the grade IV form. It is the most common malignant brain tumor in adults. In its guidance for clinicians, NCI notes that glioblastoma and anaplastic astrocytoma together account for roughly 38% of primary brain tumors.

The word primary matters here. A primary brain tumor starts in the brain. A metastatic brain tumor starts elsewhere in the body and travels there. They are not the same disease and are not treated the same way.

Why the first sign is often strange

Brain tumors rarely hurt the way a broken bone hurts. They cause trouble by pressing on tissue and by disturbing the electrical traffic around them. So the symptom depends on where the tumor sits. The parietal lobe helps the brain make sense of touch, position, and space.

NCI's patient guidance lists the signs that most often lead to a scan:

• A morning headache, or a headache that eases after vomiting.
• Seizures.
• Problems with vision, hearing, or speech.
• Frequent nausea and vomiting, or loss of appetite.
• Changes in personality, mood, focus, or behavior.
• Loss of balance and trouble walking.
• Weakness.
• Unusual sleepiness, or a change in activity level.

NCI's clinician guidance adds a useful figure. About 20% of people with a tumor in the upper part of the brain first come to medical attention because of a seizure, as Kennedy did.

When to get checked

There is no screening test for brain tumors in healthy adults. NCI's patient page offers none, because none has been shown to help. Symptoms are the only signal, so these are the ones that should move you:

• A first seizure at any age, in a person with no epilepsy diagnosis. This needs same-day emergency care.
• Sudden weakness or numbness on one side, sudden trouble speaking, or sudden loss of vision. Call 911. This may be a stroke.
• A headache that is new and different from your usual pattern, especially if it wakes you at night, is worst on waking, or is worse when you cough or bend over. Ask for a visit within days, not months.
• Any headache paired with vomiting, double vision, or a change in how you walk.
• A change in personality, memory, or coordination that builds over weeks and that other people notice before you do.

Keep the scale in mind. Headaches are close to universal. Brain and other nervous system cancers are not. SEER, the federal cancer surveillance program, puts new cases in the United States at 24,740 for 2026, and credits that projection to the American Cancer Society. That is about 1.2% of all new cancer cases.

Getting to an answer

Diagnosis usually starts with a neurologic exam. A clinician checks strength, reflexes, balance, vision, and speech. Imaging comes next. MRI with gadolinium, a contrast agent that makes tumors light up, is the main test. CT, PET, and SPECT scans may be added.

Scans can suggest a tumor. Only tissue can name it. A biopsy is taken either through a small opening using stereotactic guidance, or during open surgery to remove the tumor. Labs then look for specific molecular markers. Two matter most in gliomas.

MGMT is a gene that helps cells repair chemotherapy damage. When its promoter is methylated, the gene is switched down and chemotherapy works better. NCI calls MGMT promoter methylation an independent marker of improved survival. IDH is a different gene. In the low-grade glioma analysis NCI cites, patients whose tumors were IDH wild-type, meaning no IDH variant, had the worst prognosis whichever treatment they received.

What treatment involves

NCI describes a clear standard for newly diagnosed glioblastoma. Surgery comes first, to take out as much tumor as can be removed safely. Then radiation therapy and daily temozolomide, a chemotherapy pill, are given together. That phase runs about six weeks. Six more cycles of temozolomide follow.

Total removal is rarely possible. Glioblastoma sends cells out into normal brain tissue, past the edge that shows on a scan. That is why radiation and drugs follow surgery instead of replacing it.

What the survival numbers mean, and do not mean

Numbers here describe groups, not people. In the trial NCI cites for the current standard, 16.0% of people treated with radiation plus temozolomide were alive three years later. For 2026 the American Cancer Society projects 18,350 deaths from brain and other nervous system cancers in the United States, about 2.9% of cancer deaths, and SEER reprints that number. NCI's own SEER data put the median age at diagnosis for brain and other nervous system cancer at 61.

None of that predicts one person's course. A statistic is a summary of many past patients treated with past methods. It is a starting point for a conversation with a neuro-oncologist, not an answer about you.

Why this story still earns space

Kennedy's diagnosis pushed a rare, hard cancer into public view. The useful part to carry forward is not one man's timeline. It is knowing that a first adult seizure is an emergency, that MRI plus biopsy is how gliomas are named, and that molecular testing now shapes the plan.

Sources

• NCI: Central Nervous System Tumors Treatment (PDQ) — Health Professional Version
• NCI: Adult Central Nervous System Tumors Treatment (PDQ) — Patient Version
• SEER Cancer Stat Facts: Brain and Other Nervous System Cancer
• American Cancer Society: Cancer Facts & Statistics
• MedlinePlus: Brain Tumors
• Scientific American: Ted Kennedy Diagnosed with Malignant Brain Tumor
• NPR: Understanding Sen. Kennedy's Cancer Diagnosis
• NPR: Doctors: Kennedy Brain Surgery a Success